Newborn screening quality assurance
- 21 September 2000
- book chapter
- Published by Oxford University Press (OUP)
Abstract
This chapter discusses quality assurance (QA) for newborn screening programs. It describes the Newborn Screening Quality Assurance Program (NSQAP) at the CDC in Atlanta, Georgia, which provides services for laboratories that use specimens of dried-blood spots (DBSs) to perform newborn screening tests. The mission of this program is to improve interlaboratory comparability and to work toward interlaboratory standardization.Keywords
This publication has 7 references indexed in Scilit:
- Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States.American Journal of Public Health, 1997
- Guidelines for the Retention, Storage, and Use of Residual Dried Blood Spot Samples after Newborn Screening Analysis: Statement of the Council of Regional Networks for Genetic ServicesBiochemical and Molecular Medicine, 1996
- Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation FrequenciesPediatric Research, 1995
- U.S. newborn screening system guidelines: Statement of the council of regional networks for genetic servicesScreening, 1992
- The origin of newborn screeningScreening, 1992
- Utility of PCR for DNA analysis from dried blood spots on filter paper blotters.Genome Research, 1991
- Phenylketonuria Screening ProgramsNew England Journal of Medicine, 1963